Procurement Summary
Country: Brazil
Summary: Register of Prices for Manipulated Medicines
Deadline: 11 May 2026
Posting Date: 27 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140224434
Document Ref. No.: 90197/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Record of Prices for Manipulated Medicines UASG code: 450161 Notice from: 04/27/2026 from 08:30 to 17:30 Proposal Delivery: from 04/27/2026 at 08:30 am GLUCOSE, CONCENTRATION 40%, PHARMACEUTICAL GEL FORM ORAL, ADDITIONAL FEATURE SPECIALLY MANIPULATED FORMULATION Quantity: 540 SODIUM BICARBONATE, DOSAGE 1 G, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED Quantity: 10680 LUGOL, 2% CONCENTRATION, PHARMACEUTICAL FORM ORAL SOLUTION, ADDITIONAL SPECIALLY MANIPULATED FORMULATION Quantity: 20 CALCIUM CARBONATE, CONCENTRATION 1 G, PHARMACEUTICAL FORM ORAL POWDER, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED FORMULATION Quantity: 10330 POLYETHYLENE GLYCOL, COMPOSITION 4000, PHARMACEUTICAL FORM POWDER ORAL Quantity: 1160 ETHYL ALCOHOL, ABSOLUTE ALCOHOLIC CONTENT, MINIMUM OF 99.5%, PHARMACEUTICAL FORM INJECTABLE SOLUTION, SPECIALLY HANDLED ADDITIONAL Quantity: 1370 CALCIUM ETHYLENEDIAMINOTETRACETIC, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE, SPECIALLY MANIPULATED ADDITIONAL FEATURE Quantity: 80 SODIUM THIOSULFATE, CONCENTRATION 250 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, SPECIALLY HANDLED ADDITIONAL CHARACTERISTICS Quantity: 250 ACTIVATED CHARCOAL, FORM PHARMACEUTICAL POWDER, ADDITIONAL CHARACTERISTICS SPECIALLY HANDLED FORMULATION Quantity: 130 PAPAIN, 3% CONCENTRATION, GEL PHARMACEUTICAL FORM, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION Quantity: 2810 METHYTHONIUM CHLORIDE, CONCENTRATION 2%, PHARMACEUTICAL FORM INJECTABLE SOLUTION, SPECIALLY HANDLED ADDITIONAL CHARACTERISTICS Quantity: 1440 DIPIRIDAMOL, DOSAGE 5 MG/ML, INJECTABLE SOLUTION INDICATIONS Quantity: 940 ISOPRENALINE, CONCENTRATION 0.2 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FEATURE SPECIALLY MANIPULATED FORMULATION Quantity: 130...
Documents
Tender Notice